On Thursday, shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA) marked $16.81 per share versus a previous $16.49 closing price. With having a 1.94% gain, an insight into the fundamental values of Intellia Therapeutics, Inc., investors would also find a great ally in the technical patterns of the stock movements showed in stock charts.

10/31/2019 · Find the latest Intellia Therapeutics, Inc. (NTLA) stock quote, history, news and other vital information to help you with your stock trading and investing. What's going on at Intellia Therapeutics (NASDAQ:NTLA)? View breaking news headlines for NTLA stock from trusted media outlets at MarketBeat. Intellia Therapeutics (NTLA) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more. 3/18/2019 · Stock analysis for Intellia Therapeutics Inc (NTLA:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company 11/28/2019 · Consulta las últimas cotizaciones de acciones, historial, noticias y otra información vital de Intellia Therapeutics, Inc. (NTLA) para ayudarte con tus Stocks Under $10. Trifecta Stocks. Top Stocks. Real Money Pro Portfolio. Intellia therapeutics (ntla) ceo bermingham explains the future of gene-editing on cnbc.

Get today's Intellia Therapeutics Inc stock news. We cover the latest Intellia Therapeutics Inc headlines and breaking news impacting Intellia Therapeutics Inc stock

7 brokerages have issued twelve-month price targets for Intellia Therapeutics' stock. Their forecasts range from $16.00 to $57.50. On average, they expect Intellia Therapeutics' share price to reach $26.92 in the next year. This suggests a possible upside of 83.5% from the stock's current price. View Analyst Price Targets for Intellia Therapeutics. cotización Intellia Therapeutics y gráficas 0JBU. Gratis precios de la bolsa en tiempo real, y los foros más activos del mercado accionario. Cotización Intellia Therapeutics (0JBU), gráficas, operaciones, ranking de las acciones, índices, blogs y foros más populares de la BMV y mucho más. Where Does Intellia Therapeutics, Inc. (NTLA) Stock Can Go From Here? Finance. Is Something Really Weird Happening In Intellia Therapeutics (NTLA), NTLA, Intellia Therapeutics - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines Acer Therapeutics (ACER) Receives a Buy from H.C. Wainwright; Analysts Are Bullish on These Healthcare Stocks: Axsome Therapeutics (AXSM), Kindred Biosciences (KIN) Wave Life Sciences (WVE) Gets a Buy Rating from H.C. Wainwright

On Thursday, shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA) marked $16.81 per share versus a previous $16.49 closing price. With having a 1.94% gain, an insight into the fundamental values of Intellia Therapeutics, Inc., investors would also find a great ally in the technical patterns of the stock movements showed in stock charts.

12/30/2019 · Real time Intellia Therapeutics (NTLA) stock price quote, stock graph, news & analysis. Find the latest news headlines from Intellia Therapeutics, Inc. Common Stock (NTLA) at Nasdaq.com. Intellia Therapeutics, Inc. (NTLA) Reports Q3 Loss, Tops Revenue Estimates Intellia Therapeutics, Inc. (NTLA) delivered earnings and revenue surprises of 19.67% and 16.15%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

Stocks Rankings for NTLA. U.S. News compares companies to their industry peers based on a variety of company fundamentals, performance metrics and investor preferences to help you find the right stocks for your investing style. Intellia Therapeutics Inc is listed as: Earnings Gainer in category

7/31/2019 · Keep this CRISPR stock on your watchlist. Investors might think that Intellia Therapeutics has been left behind by peers, but that might not be the most accurate assessment of the situation. The business may have taken a step back simply to ensure it nailed the delivery vehicle component of its drug candidates. 7/31/2019 · Keep this CRISPR stock on your watchlist. Investors might think that Intellia Therapeutics has been left behind by peers, but that might not be the most accurate assessment of the situation. The business may have taken a step back simply to ensure it nailed the delivery vehicle component of its drug candidates. Noticias Intellia Therapeutics y gráfias 0JBU. Gratis precios de la bolsa en tiempo real, y los foros más activos del mercado accionario. Cotización Intellia Therapeutics (0JBU), gráficas, operaciones, ranking de las acciones, índices, blogs y foros más populares de la BMV y mucho más. Today's High Today's Low 52 Week High 52 Week Low. Copyright West LLC. Minimum 15 minutes delayed. Contact IR You can buy and sell Intellia Therapeutics (NTLA) stock and options and many more commission-free on Robinhood with real-time quotes, market data, and relevant news. 4,589 people own Intellia Therapeutics on Robinhood on January 1, 2020. Intellia Therapeutics, Inc. (NTLA) Shares March Higher, Can It Continue? By Zacks Investment Research - Nov 06, 2019. As of late, it has definitely been a great time to be an investor in Intellia Therapeutics, Inc. (NASDAQ:NTLA) . The stock has moved higher by 22.5% in the past month, while it is also above its 20 12/20/2019 · intellia therapeutics inc (ntla): * arbitration decision affirms intellia therapeutics interpretation of licensing agreement with caribou biosciences on the crispr/cas9 technology. * intellia therapeutics inc (ntla) - parties must negotiate terms and payments to intellia for caribou's use of chemically modified guide rnas.

Intellia Therapeutics Inc. NTLA Morningstar Rating Rating as of Dec 2, 2019. Quote Stock Analysis News Price vs Fair Value Trailing Returns Financials

NTLA, Intellia Therapeutics - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines Acer Therapeutics (ACER) Receives a Buy from H.C. Wainwright; Analysts Are Bullish on These Healthcare Stocks: Axsome Therapeutics (AXSM), Kindred Biosciences (KIN) Wave Life Sciences (WVE) Gets a Buy Rating from H.C. Wainwright Become a member for free. Sign up. Sign up Why Intellia Therapeutics, Inc. (NTLA) Stock Dove Today. Lloyd Martinez-November 21, 2019. 0. Stock News. Here’s Why Intellia Therapeutics, Inc. (NTLA) Stock Rose Should You Buy Lineage Cell Therapeutics, Inc. (LCTX)’s Stock Price That’s December 30, 2019 Why Mereo BioPharma Group plc (MREO) Is An Unattractive Stock Today Intellia Therapeutics, Inc. (NTLA) Reports Q2 Loss, Tops Revenue Estimates. by Zacks Equity Research Published on August 01,2018 . Intellia Therapeutics, Inc. (NTLA) delivered earnings and revenue surprises of 8.77% and 20.20%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock? NTLA Some stocks tend always to have high volume, as they are popular among day traders and investors alike. Other stocks tend always to have low volume, and aren’t of particular interest to short-term traders. The stock average trading capacity stands with 548.39K shares and relative volume is now at 1.62. Intellia Therapeutics (NTLA):

1 day ago Intellia made significant advancements throughout 2019. The company's remains uncertain. 2020 could see wild fluctuations in the stock.